Purpose: Osteoarthritis (OA) is the most common form of arthritis and a leading cause of pain
and disability worldwide. Due to the older age profile of people with OA and the presence
of comorbidities such as cardiovascular disease, hypertension, diabetes and lung disease,
the safety of pharmacological approaches, as well as their efficacy, need to be considered
in ascertaining their role in managing OA. Pharmacological management of OA centres
on management of symptoms and includes analgesics, non-steroidal anti-inflammatory
drugs (NSAIDs), opioids and nutraceuticals (e.g. glucosamine/chondroitin sulphate).
Little is known about how OA is managed in Ireland. This research aimed to explore
the utilisation of medications and nutraceuticals typically used to manage the symptoms
of OA among individuals with self-reported OA from The Irish Longitudinal Study on
Ageing (TILDA) population cohort study. The aim of this study was to compare cross-sectional
patterns of pain medications and nutraceutical use in individuals with OA compared
to those without any type of arthritis in an Irish population cohort, and to examine
the relationship between the total number of these medications used and demographic
and clinical factors.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Osteoarthritis and CartilageAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
497
Identification
Copyright
© 2022 Published by Elsevier Inc.
